Intravenous immunoglobulins containing antibodies against ß-amyloid for the treatment of Alzheimer's disease

Methods: Five patients with AD were enrolled and received monthly IVIgG over a 6 month period. Efficacy assessment included total Aß/Aß(1–42) measured in the CSF/serum as well as effects on cognition (ADAS-cog; CERAD) at baseline and at 6 months following IVIgG. Results: Following IVIgG, total Aß le...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dodel, R, Du, Y, Depboylu, C, Hampel, H, Frolich, L, Haag, A, Hemmeter, U, Paulsen, S, Teipel, S, Brettschneider, S, Spottke, A, Nolker, C, Moller, H, Wei, X, Farlow, M, Sommer, N, Oertel, W
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2004
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1738770/
https://ncbi.nlm.nih.gov/pubmed/15377700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2003.033399
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados